Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer (Q57152489)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

title

Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Yong-Chen Lu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

13

Steven A Rosenberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Eric Tran

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Simon Turcotte

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Paul F Robbins

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Mark E Dudley

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

John R Wunderlich

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Robert P Somerville

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Katherine Hogan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Christian S Hinrichs

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Maria R Parkhurst

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

James C Yang

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

language of work or name

English

0 references

publication date

1 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

volume

344

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

page(s)

641-645

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

issue

6184

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

cites work

Cancer genome landscapes

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

Mutated PPP1R3B is recognized by T cells used to treat a melanoma patient who experienced a durable complete tumor regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

Antigen spreading contributes to MAGE vaccination-induced regression of melanoma metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

Long-term follow-up of patients with resected pancreatic cancer following vaccination against mutant K-ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

Primary antitumor immune response mediated by CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

Polyfunctional CD4⁺ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

T-helper-1-cell cytokines drive cancer into senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

Phenotype and function of T cells infiltrating visceral metastases from gastrointestinal cancers and melanoma: implications for adoptive cell transfer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1251102

High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24812403

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A point mutation in the alpha-actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human lung carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24812403

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24812403

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1126/SCIENCE.1251102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24812403%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference